97 related articles for article (PubMed ID: 9254267)
1. [Immunological monitoring of patients with disseminated colorectal cancer under thermochemotherapy].
Iaremchuk AIa; Kravchenko AV; Kamenets LIa; Chernenko OD
Klin Khir; 1997; (1):35-7. PubMed ID: 9254267
[TBL] [Abstract][Full Text] [Related]
2. Comparison of chemotherapy and X-ray therapy with Ukrain monotherapy for colorectal cancer.
Susak YM; Zemskov VS; Yaremchuk OY; Kravchenco OB; Yatsyk IM; Korsh OB
Drugs Exp Clin Res; 1996; 22(3-5):115-22. PubMed ID: 8899313
[TBL] [Abstract][Full Text] [Related]
3. [Long-term prognosis for colorectal carcinoma treated with adjuvant immunochemotherapy].
Sakai T; Yamashita Y
Nihon Rinsho; 2003 Sep; 61 Suppl 7():460-3. PubMed ID: 14574935
[No Abstract] [Full Text] [Related]
4. A randomized phase II trial of 5-fluorouracil, with or without human interferon-beta, for advanced colorectal cancer.
Villar-Grimalt A; Candel MT; Massuti B; Lizón J; Sánchez B; Frau A; Gorostidi B; Goedkoop R
Br J Cancer; 1999 May; 80(5-6):786-91. PubMed ID: 10360656
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.
Jover R; Castells A; Llor X; Andreu M
Gut; 2006 Dec; 55(12):1819-20. PubMed ID: 17124161
[No Abstract] [Full Text] [Related]
6. Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.
Iacopetta B; Watanabe T
Gut; 2006 Nov; 55(11):1671-2. PubMed ID: 17047121
[No Abstract] [Full Text] [Related]
7. Beyond 5-fluorouracil monochemotherapy in colorectal cancer--it is time.
Satta F; Franchi F
J Chemother; 1997 Dec; 9(6):431-5. PubMed ID: 9491844
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy of colorectal cancer.
Cunningham D; Starling N
Lancet; 2007 Dec; 370(9604):1980-1. PubMed ID: 18083386
[No Abstract] [Full Text] [Related]
9. Chemotherapy for colorectal cancer.
Nicum S; Midgley R; Kerr DJ
J R Soc Med; 2000 Aug; 93(8):416-9. PubMed ID: 10983503
[No Abstract] [Full Text] [Related]
10. Prospective evaluation of fluorouracil chemotherapy based on the genetic makeup of colorectal cancer.
Carethers JM
Gut; 2006 Dec; 55(12):1819. PubMed ID: 17124162
[No Abstract] [Full Text] [Related]
11. Locally advanced primary colorectal cancer: IOERT and EBRT +/-5-FU.
Gunderson LL; Nelson H; Martenson JA; Cha S; Haddock MG; Devine RM; Fieck JM; Wolff BG; Dozois RR; O'Connell MJ
Front Radiat Ther Oncol; 1997; 31():204-8. PubMed ID: 9263823
[No Abstract] [Full Text] [Related]
12. Lack of benefit of 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer with microsatellite instability.
Johnson L; Chu E
Clin Colorectal Cancer; 2002 Nov; 2(3):146-8. PubMed ID: 12482330
[No Abstract] [Full Text] [Related]
13. A randomized controlled trial of postoperative adjuvant immunochemotherapy for colorectal cancer with oral medicines.
Koda K; Miyazaki M; Sarashina H; Suwa T; Saito N; Suzuki M; Ogawa K; Watanabe S; Kodaira S; Nakazato H
Int J Oncol; 2003 Jul; 23(1):165-72. PubMed ID: 12792790
[TBL] [Abstract][Full Text] [Related]
14. On 5-fluorouracil therapy of colorectal cancer.
Jensen SA
Dan Med J; 2013 Jul; 60(7):B4603. PubMed ID: 23809976
[No Abstract] [Full Text] [Related]
15. Therapy for colorectal cancer.
Jankilevich G
N Engl J Med; 2005 Apr; 352(17):1820-2; author reply 1820-2. PubMed ID: 15864822
[No Abstract] [Full Text] [Related]
16. Mechanism of action of fluoropyrimidines: relevance to the new developments in colorectal cancer chemotherapy.
Sobrero A; Guglielmi A; Grossi F; Puglisi F; Aschele C
Semin Oncol; 2000 Oct; 27(5 Suppl 10):72-7. PubMed ID: 11049035
[No Abstract] [Full Text] [Related]
17. Enhanced efficacy of conditionally replicating herpes simplex virus (G207) combined with 5-fluorouracil and surgical resection in peritoneal cancer dissemination models.
Nakano K; Todo T; Zhao G; Yamaguchi K; Kuroki S; Cohen JB; Glorioso JC; Tanaka M
J Gene Med; 2005 May; 7(5):638-48. PubMed ID: 15754306
[TBL] [Abstract][Full Text] [Related]
18. Locally recurrent colorectal cancer: IOERT and EBRT +/-5-FU and maximal resection.
Gunderson LL; Haddock MG; Nelson H; Cha S; Devine RM; Fieck JM; Wolff BG; Dozois RR; O'Connell MJ
Front Radiat Ther Oncol; 1997; 31():224-8. PubMed ID: 9263828
[No Abstract] [Full Text] [Related]
19. [Colorectal carcinoma: therapeutic approach in patients already treated with metastasis resection].
Bajetta E; Cappuzzo F
Ann Ital Chir; 1996; 67(6):827-30. PubMed ID: 9214274
[TBL] [Abstract][Full Text] [Related]
20. Tumour site, sex, and survival in colorectal cancer.
Rosell R; Abad A
Lancet; 2000 Sep; 356(9232):857; author reply 858. PubMed ID: 11022957
[No Abstract] [Full Text] [Related]
[Next] [New Search]
